Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Red5 Pharmaceuticals

Red5 Pharmaceuticals?uq=w9if130k
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$60K LATEST DEAL AMOUNT
3 INVESTORS
Description

Innovator of therapeutic agents against cancer. The company's platform performs the chemical synthesis and pharmaceutical testing of non-natural nucleosides as novel anti-cancer agents against hematological cancers and solid tumors.

Formerly Known As
Red5 Pharma
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Other Healthcare Technology Systems
Primary Office
  • 11000 Euclid Avenue
  • Cleveland, OH 44106
  • United States

+1 (216) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Red5 Pharmaceuticals’s full profile, request a free trial.

Red5 Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 12-Feb-2015 $60K Completed Startup
1. Accelerator/Incubator 03-Jun-2014 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Red5 Pharmaceuticals Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Ohio Third Frontier Lender/Debt Provider 000 0000 000000 0
Great Lakes Innovation and Development Enterprise Accelerator/Incubator 000 0000 000000 0
Innovation Fund of Northeast Ohio Accelerator/Incubator 000 0000 000000 0

Red5 Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
Anthony Berdis Ph.D Co-Founder & Chief Scientific Officer
Timothy Miller Ph.D Co-Founder & Chairman

Red5 Pharmaceuticals Board Members (1)

Name Representing Role Since Contact
Info
Timothy Miller Ph.D Self Co-Founder & Chairman 000 0000